The DOI matches its Crossref record; 180 of the 180 references it cites were found in a registry or an index.
Cannabinoid Receptor Signaling
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., Felder, C. C., Herkenham, M., Mackie, K., Martin, B. R., et al. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.161 · Cited by 2,819
Self-citationDetermination and characterization of a cannabinoid receptor in rat brain
Devane, W. A., Dysarz, F. A., Johnson, M. R., Melvin, L. S., & Howlett, A. C. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09876-1 · Cited by 2,443
Self-citationCannabinoid receptor localization in brain.
Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1932 · Cited by 2,321
Herkenham, M., Lynn, A., Johnson, M., Melvin, L., de Costa, B., & Rice, K. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-02-00563.1991 · Cited by 2,159
The molecular logic of endocannabinoid signalling
Piomelli, D. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1247 · Cited by 1,957
SR141716A, a potent and selective antagonist of the brain cannabinoid receptor
Rinaldi-Carmona, M., Barth, F., Héaulme, M., Shire, D., Calandra, B., Congy, C., Martinez, S., Maruani, J., Néliat, G., Caput, D., et al. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00773-x · Cited by 1,757
Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses
Wilson, R. I., & Nicoll, R. A. (2001) · Nature · doi:10.1038/35069076 · Cited by 1,607
Role of Endogenous Cannabinoids in Synaptic Signaling
FREUND, T. F., KATONA, I., & PIOMELLI, D. (2003) · Physiological Reviews · doi:10.1152/physrev.00004.2003 · Cited by 1,574
Pharmacology of cannabinoid CB1 and CB2 receptors
Pertwee, R. G. (1997) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(97)82001-3 · Cited by 1,470
Endocannabinoid Signaling in the Brain
Wilson, R. I., & Nicoll, R. A. (2002) · Science · doi:10.1126/science.1063545 · Cited by 1,260
Felder, C. C., Joyce, K. E., Briley, E. M., Mansouri, J., Mackie, K., Blond, O., Lai, Y., Ma, A. L., & Mitchell, R. L. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10492-6 · Cited by 869
Postsynaptic endocannabinoid release is critical to long-term depression in the striatum
Gerdeman, G. L., Ronesi, J., & Lovinger, D. M. (2002) · Nature Neuroscience · doi:10.1038/nn832 · Cited by 767
SR 144528, the First Potent and Selective Antagonist of the CB2 Cannabinoid Receptor
Rinaldi-Carmona, M., Barth, F., Millan, J., Derocq, J.-M., Casellas, P., Congy, C., Oustric, D., Sarran, M., Bouaboula, M., Calandra, B., et al. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37266-0 · Cited by 709
Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells.
Mackie, K., & Hille, B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.9.3825 · Cited by 694
Glass, M., & Felder, C. C. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-14-05327.1997 · Cited by 635
Mackie, K., Lai, Y., Westenbroek, R., & Mitchell, R. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-10-06552.1995 · Cited by 626
Retrograde signaling in the regulation of synaptic transmission: focus on endocannabinoids
E. Alger, B. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00080-1 · Cited by 598
Maejima, T., Hashimoto, K., Yoshida, T., Aiba, A., & Kano, M. (2001) · Neuron · doi:10.1016/s0896-6273(01)00375-0 · Cited by 555
Presynaptic Specificity of Endocannabinoid Signaling in the Hippocampus
Wilson, R. I., Kunos, G., & Nicoll, R. A. (2001) · Neuron · doi:10.1016/s0896-6273(01)00372-5 · Cited by 544
Bouaboula, M., Poinot-Chazel, C., Bourrié, B., Canat, X., Calandra, B., Rinaldi-Carmona, M., Le Fur, G., & Casellas, P. (1995) · Biochemical Journal · doi:10.1042/bj3120637 · Cited by 543
Pharmacology of Cannabinoid Receptor Ligands
Pertwee, R. G. (1999) · Current Medicinal Chemistry · doi:10.2174/0929867306666220401124036 · Cited by 526
Induction of Nitric Oxide Synthase in Glial Cells
Simmons, M. L., & Murphy, S. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb08328.x · Cited by 491
Pharmacology of Cannabinoid Receptors
Howlett, A. C. (1995) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.35.040195.003135 · Cited by 488
Self-citationFelder, C. C., Briley, E. M., Axelrod, J., Simpson, J. T., Mackie, K., & Devane, W. A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.16.7656 · Cited by 475
Involvement of Gi in the inhibition of adenylate cyclase by cannabimimetic drugs.
Howlett, A. C., Qualy, J. M., & Khachatrian, L. L. (1986) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10219-8 · Cited by 469
Self-citationValjent, E., Pagès, C., Hervé, D., Girault, J., & Caboche, J. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03278.x · Cited by 438
Metabotropic Glutamate Receptors Drive the Endocannabinoid System in Hippocampus
Varma, N., Carlson, G. C., Ledent, C., & Alger, B. E. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-24-j0003.2001 · Cited by 406
Howlett, A. C., & Fleming, R. M. (1984) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)15066-9 · Cited by 375
Self-citationGonsiorek, W., Lunn, C., Fan, X., Narula, S., Lundell, D., & Hipkin, R. W. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)26516-0 · Cited by 369
Mackie, K., Devane, W. A., & Hille, B. (1993) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13215-x · Cited by 362
De Petrocellis, L., Bisogno, T., Maccarrone, M., Davis, J. B., Finazzi-Agrò, A., & Di Marzo, V. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008555200 · Cited by 355
Carrier, E. J., Kearn, C. S., Barkmeier, A. J., Breese, N. M., Yang, W., Nithipatikom, K., Pfister, S. L., Campbell, W. B., & Hillard, C. J. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.4.999 · Cited by 336
Functional CB1 cannabinoid receptors in human vascular endothelial cells
Liu, J., Gao, B., Mirshahi, F., Sanyal, A. J., Khanolkar, A. D., Makriyannis, A., & Kunos, G. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3460835 · Cited by 333
Regulation of Extracellular Signal-Regulated Kinase by Cannabinoids in Hippocampus
Derkinderen, P., Valjent, E., Toutant, M., Corvol, J.-C., Enslen, H., Ledent, C., Trzaskos, J., Caboche, J., & Girault, J.-A. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-06-02371.2003 · Cited by 331
Kim, J., Isokawa, M., Ledent, C., & Alger, B. E. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-23-10182.2002 · Cited by 318
Sim, L. J., Hampson, R. E., Deadwyler, S. A., & Childers, S. R. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-24-08057.1996 · Cited by 312
Evidence That the Cannabinoid CB1 Receptor Is a 2-Arachidonoylglycerol Receptor
Sugiura, T., Kodaka, T., Nakane, S., Miyashita, T., Kondo, S., Suhara, Y., Takayama, H., Waku, K., Seki, C., Baba, N., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.5.2794 · Cited by 310
Gebremedhin, D., Lange, A. R., Campbell, W. B., Hillard, C. J., & Harder, D. R. (1999) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1999.276.6.h2085 · Cited by 308
Ohno-Shosaku, T., Tsubokawa, H., Mizushima, I., Yoneda, N., Zimmer, A., & Kano, M. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-10-03864.2002 · Cited by 301
Vogel, Z., Barg, J., Levy, R., Saya, D., Heldman, E., & Mechoulam, R. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03576.x · Cited by 300
Pharmacology and stereoselectivity of structurally novel cannabinoids in mice.
Little, P. J., Compton, D. R., Johnson, M. R., Melvin, L. S., & Martin, B. R. (1988) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)13256-4 · Cited by 291
Compton, D. R., Gold, L. H., Ward, S. J., Balster, R. L., & Martin, B. R. (1992) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10448-5 · Cited by 288
Bouaboula, M., Poinot‐Chazel, C., Marchand, J., Canat, X., Bourrié, B., Rinaldi‐Carmona, M., Calandra, B., Le Fur, G., & Casellas, P. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.0704p.x · Cited by 286
Mechanism of Cannabinoid Effects on Long-Term Potentiation and Depression in Hippocampal CA1 Neurons
Misner, D. L., & Sullivan, J. M. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-16-06795.1999 · Cited by 285
Caulfield, M. P., & Brown, D. A. (1992) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1992.tb14321.x · Cited by 278
Breivogel, C. S., Childers, S. R., Deadwyler, S. A., Hampson, R. E., Vogt, L. J., & Sim‐Selley, L. J. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0732447.x · Cited by 273
Regulation of Cannabinoid CB1 Receptors in the Central Nervous System by Chronic Cannabinoids
Sim-Selley, L. J. (2003) · Critical Reviews in Neurobiology · doi:10.1615/critrevneurobiol.v15.i2.10 · Cited by 271
Distinct Domains of the CB1 Cannabinoid Receptor Mediate Desensitization and Internalization
Jin, W., Brown, S., Roche, J. P., Hsieh, C., Celver, J. P., Kovoor, A., Chavkin, C., & Mackie, K. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-10-03773.1999 · Cited by 261
Felder, C. C., Veluz, J. S., Williams, H. L., Briley, E. M., & Matsuda, L. A. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09174-6 · Cited by 261
The CB1 cannabinoid receptor is coupled to the activation of protein kinase B/Akt
del Pulgar, T. G., Velasco, G., & Guzmán, M. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3470369 · Cited by 259
Cellular effects of cannabinoids.
Martin, B. R. (1986) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06860-7 · Cited by 255
Howlett, A. C. (1985) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)12377-8 · Cited by 255
Self-citationRueda, D., Navarro, B., Martı́nez-Serrano, A., Guzmán, M., & Galve-Roperh, I. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206590200 · Cited by 254
Howlett, A. C., Johnson, M. R., Melvin, L. S., & Milne, G. M. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13196-9 · Cited by 253
Self-citationDeadwyler, S. A., Hampson, R. E., Mu, J., Whyte, A., & Childers, S. (1995) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)09495-9 · Cited by 241
2-Arachidonoylglycerol and the cannabinoid receptors
Sugiura, T., & Waku, K. (2000) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(00)00189-4 · Cited by 235
Felder, C. C., Joyce, K. E., Briley, E. M., Glass, M., Mackie, K. P., Fahey, K. J., Cullinan, G. J., Hunden, D. C., Johnson, D. W., Chaney, M. O., et al. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37189-7 · Cited by 233
Cellular signal transduction by anandamide and 2-arachidonoylglycerol
Howlett, A. C., & Mukhopadhyay, S. (2000) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(00)00187-0 · Cited by 229
Self-citationRonesi, J., Gerdeman, G. L., & Lovinger, D. M. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.5214-03.2004 · Cited by 228
Mechanisms of Endocannabinoid Inactivation: Biochemistry and Pharmacology
Giuffrida, A., Beltramo, M., & Piomelli, D. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29345-9 · Cited by 226
Bonhaus, D. W., Chang, L. K., Kwan, J., & Martin, G. R. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37876-0 · Cited by 223
Dual Effects of Anandamide on NMDA Receptor‐Mediated Responses and Neurotransmission
Hampson, A. J., Bornheim, L. M., Scanziani, M., Yost, C. S., Gray, A. T., Hansen, B. M., Leonoudakis, D. J., & Bickler, P. E. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70020671.x · Cited by 208
Discovery and characterization of endogenous cannabinoids
Martin, B. R., Mechoulam, R., & Razdan, R. K. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00281-7 · Cited by 202
The CB1 Cannabinoid Receptor Is Coupled to the Activation of c-Jun N-Terminal Kinase
Rueda, D., Galve-Roperh, I., Haro, A., & Guzmán, M. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)23114-x · Cited by 200
Molina-Holgado, F., Pinteaux, E., Moore, J. D., Molina-Holgado, E., Guaza, C., Gibson, R. M., & Rothwell, N. J. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-16-06470.2003 · Cited by 192
Sánchez, C., Galve-Roperh, I., Rueda, D., & Guzmán, M. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.5.834 · Cited by 192
Activation of the human peripheral cannabinoid receptor results in inhibition of adenylyl cyclase.
Slipetz, D. M., O'Neill, G. P., Favreau, L., Dufresne, C., Gallant, M., Gareau, Y., Guay, D., Labelle, M., & Metters, K. M. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10254-x · Cited by 191
Jeon, Y. J., Yang, K. H., Pulaski, J. T., & Kaminski, N. E. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09237-5 · Cited by 190
Guo, J., & Ikeda, S. R. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.3.665 · Cited by 190
Mechanism of Extracellular Signal-Regulated Kinase Activation by the CB1 Cannabinoid Receptor
Galve-Roperh, I., Rueda, D., Gómez del Pulgar, T., Velasco, G., & Guzmán, M. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.6.1385 · Cited by 185
Stefano, G. B., Liu, Y., & Goligorsky, M. S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.32.19238 · Cited by 185
Pan, X., Ikeda, S. R., & Lewis, D. L. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.6.1064 · Cited by 185
Anandamide Uptake by Human Endothelial Cells and Its Regulation by Nitric Oxide
Maccarrone, M., Bari, M., Lorenzon, T., Bisogno, T., Di Marzo, V., & Finazzi-Agrò, A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.18.13484 · Cited by 184
Regulation of a Neuronal Form of Focal Adhesion Kinase by Anandamide
Derkinderen, P., Toutant, M., Burgaya, F., Le Bert, M., Siciliano, J. C., de Franciscis, V., Gelman, M., & Girault, J.-A. (1996) · Science · doi:10.1126/science.273.5282.1719 · Cited by 180
Ohno‐Shosaku, T., Shosaku, J., Tsubokawa, H., & Kano, M. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.01929.x · Cited by 179
Oviedo, A., Glowa, J., & Herkenham, M. (1993) · Brain Research · doi:10.1016/0006-8993(93)90220-h · Cited by 179
The central neuropharmcology of psychotropic cannabinoids
Pertwee, R. G. (1988) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(88)90106-4 · Cited by 178
Effects of anandamide on cannabinoid receptors in rat brain membranes
Childers, S. R., Sexton, T., & Roy, M. B. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90134-1 · Cited by 176
Stimulation of Cannabinoid Receptor CB1 Induces krox-24 Expression in Human Astrocytoma Cells
Bouaboula, M., Bourrié, B., Rinaldi-Carmona, M., Shire, D., Fur, G. L., & Casellas, P. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.23.13973 · Cited by 175
De Fonseca, F. R., Gorriti, M. A., Fernández-Ruiz, J. J., Palomo, T., & Ramos, J. A. (1994) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(94)90108-2 · Cited by 175
Henry, D. J., & Chavkin, C. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11289-9 · Cited by 173
The MAP kinase signal transduction pathway is activated by the endogenous cannabinoid anandamide
Wartmann, M., Campbell, D., Subramanian, A., Burstein, S. H., & Davis, R. J. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00027-7 · Cited by 173
Inhibition of Interneuron Firing Extends the Spread of Endocannabinoid Signaling in the Cerebellum
Kreitzer, A. C., Carter, A. G., & Regehr, W. G. (2002) · Neuron · doi:10.1016/s0896-6273(02)00695-5 · Cited by 167
Sugiura, T., Kodaka, T., Kondo, S., Tonegawa, T., Nakane, S., Kishimoto, S., Yamashita, A., & Waku, K. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1757 · Cited by 164
The uptake by cells of 2‐arachidonoylglycerol, an endogenous agonist of cannabinoid receptors
Bisogno, T., Maccarrone, M., De Petrocellis, L., Jarrahian, A., Finazzi‐Agrò, A., Hillard, C., & Di Marzo, V. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02072.x · Cited by 160
McAllister, S. D., Griffin, G., Satin, L. S., & Abood, M. E. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35147-x · Cited by 160
Cannabinoid receptor activation differentially regulates the various adenylyl cyclase isozymes
Rhee, M., Bayewitch, M., Avidor‐Reiss, T., Levy, R., & Vogel, Z. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71041525.x · Cited by 159
Cannabinoids activate p38 mitogen‐activated protein kinases through CB1 receptors in hippocampus
Derkinderen, P., Ledent, C., Parmentier, M., & Girault, J. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00333.x · Cited by 159
Role of cyclic AMP in the actions of cannabinoid receptors
Childers, S. R., & Deadwyler, S. A. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(96)00419-4 · Cited by 159
Pathways and mechanisms of N-acylethanolamine biosynthesis: can anandamide be generated selectively?
Schmid, H. H. O. (2000) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(00)00188-2 · Cited by 157
Inhibition of neuroblastoma adenylate cyclase by cannabinoid and nantradol compounds
Howlett, A. C. (1984) · Life Sciences · doi:10.1016/0024-3205(84)90278-9 · Cited by 156
Self-citationProtein Kinase C Disrupts Cannabinoid Actions by Phosphorylation of the CB1 Cannabinoid Receptor
García, D. E., Brown, S. M., Hille, B., & Mackie, K. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-08-02834.1998 · Cited by 155
Nucleotide sequence of a human cannabinoid receptor cDNA
Gérard, C., Mollereau, C., Vassart, G., & Parmentier, M. (1990) · Nucleic Acids Research · doi:10.1093/nar/18.23.7142 · Cited by 152
Romero, J., García‐Palomero, E., Castro, J. G., García-Gil, L., Ramos, J. A., & Fernández‐Ruíz, J. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(96)00277-x · Cited by 150
Vásquez, C., & Lewis, D. L. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-21-09271.1999 · Cited by 150
Molina‐Holgado, F., Molina‐Holgado, E., Guaza, C., & Rothwell, N. J. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10165 · Cited by 148
Shen, M., & Thayer, S. A. (1998) · Brain Research · doi:10.1016/s0006-8993(97)01195-5 · Cited by 146
Maejima, T., Ohno‐Shosaku, T., & Kano, M. (2001) · Neuroscience Research · doi:10.1016/s0168-0102(01)00241-3 · Cited by 139
D2 Dopamine Receptors Modulate Gα-Subunit Coupling of the CB1 Cannabinoid Receptor
Jarrahian, A., Watts, V. J., & Barker, E. L. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.057620 · Cited by 135
Cannabimimetic fatty acid derivatives: the anandamide family and other endocannabinoids.
Marzo, V. D., Bisogno, T., PETROCELLIS, L. D., Melck, D. J., & Martin, B. R. (1999) · PubMed · Cited by 132
A role for endocannabinoids in indomethacin-induced spinal antinociception
Gühring, H., Hamza, M., Sergejeva, M., Ateş, M., Kotalla, C., Ledent, C. A., & Brune, K. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02485-8 · Cited by 129
Sugiura, T., Kodaka, T., Kondo, S., et al. (1997) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a021838 · Cited by 129
Howlett, A. C., Champion, T. M., Wilken, G. H., & Mechoulam, R. (1990) · Neuropharmacology · doi:10.1016/0028-3908(90)90056-w · Cited by 126
Self-citationThe Cannabinoids as Potential Antiepileptics
Karler, R., & Turkanis, S. A. (1981) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1981.tb02624.x · Cited by 124
Aminoalkylindoles: actions on specific G-protein-linked receptors.
Pacheco, M., Childers, S. R., Arnold, R. A., Casiano, F. M., & Ward, S. J. (1991) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24755-3 · Cited by 124
Thomas, B. F., Compton, D. M., & Martin, B. R. (1990) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23000-2 · Cited by 121
Maneuf, Y. P., & Brotchie, J. M. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701101 · Cited by 120
Cannabimimetic Fatty Acid Derivatives: The Anandamide Family and Other 'Endocannabinoids'
Melck, D. J., Marzo, V. D., Bisogno, T., PETROCELLIS, L. D., & Martin, B. R. (1999) · Current Medicinal Chemistry · doi:10.2174/0929867306666220401141630 · Cited by 119
Galante, M., & Diana, M. A. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.0403-04.2004 · Cited by 118
Calcium Dependence of Retrograde Inhibition by Endocannabinoids at Synapses onto Purkinje Cells
Brenowitz, S. D., & Regehr, W. G. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-15-06373.2003 · Cited by 116
Davis, M. I., Ronesi, J. A., & Lovinger, D. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305697200 · Cited by 112
Hillard, C. J., Harris, R. A., & Bloom, A. S. (1985) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20892-8 · Cited by 111
Alger, B. E., Pitler, T. A., Wagner, J. J., Martin, L. A., Morishita, W., Kirov, S. A., & Lenz, R. A. (1996) · The Journal of Physiology · doi:10.1113/jphysiol.1996.sp021677 · Cited by 110
Anandamide suppresses nitric oxide and TNF-α responses to Theilerʼs virus or endotoxin in astrocytes
Molina‐Holgado, F., Lledó, A., & Guaza, C. (1997) · Neuroreport · doi:10.1097/00001756-199705260-00027 · Cited by 110
Morishita, W., Kirov, S. A., & Alger, B. E. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-13-04870.1998 · Cited by 109
Cannabinoid receptor binding and agonist activity of amides and esters of arachidonic acid.
PINTO, J. C., Potié, F., Rice, K. C., Boring, D. L., Johnson, M. R., Evans, D. M., Wilken, G. H., Cantrell, C. H., & Howlett, A. C. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09729-9 · Cited by 109
Self-citationASK1–p38 MAPK/JNK signaling cascade mediates anandamide‐induced PC12 cell death
Sarker, K. P., Biswas, K. K., Yamakuchi, M., Lee, K., Hahiguchi, T., Kracht, M., Kitajima, I., & Maruyama, I. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01663.x · Cited by 108
Fimiani, C., Mattocks, D. A. L., Cavani, F., Salzet, M., Deutsch, D. G., Pryor, S. C., Bilfinger, T. V., & Stefano, G. B. (1999) · Cellular Signalling · doi:10.1016/s0898-6568(98)00060-6 · Cited by 104
Sarker, K. P., & Maruyama, I. (2003) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-3055-2 · Cited by 104
Cannabinoids Enhance NMDA-Elicited Ca2+Signals in Cerebellar Granule Neurons in Culture
Netzeband, J. G., Conroy, S. M., Parsons, K. L., & Gruol, D. L. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-20-08765.1999 · Cited by 103
Abadji, V., Lucas-Lenard, J. M., Chin, C., & Kendall, D. A. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0722032.x · Cited by 101
Mukhopadhyay, S., McIntosh, H. H., Houston, D. B., & Howlett, A. C. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)26454-3 · Cited by 101
Self-citationRomero, J., García‐García, L., Fernández‐Ruíz, J., Cebeira, M., & Ramos, J. A. (1995) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)00023-p · Cited by 100
Derocq, J., Jbilo, O., Bouaboula, M., Ségui, M., Clère, C., & Casellas, P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.21.15621 · Cited by 100
Howlett, A. C. (1987) · Neuropharmacology · doi:10.1016/0028-3908(87)90035-9 · Cited by 98
Self-citationFan, F., Tao, Q., Abood, M. E., & Martin, B. R. (1996) · Brain Research · doi:10.1016/0006-8993(95)01113-7 · Cited by 97
Identification of cannabinoid receptors in cultures of rat cerebellar granule cells
Pacheco, M. A., Ward, S. J., & Childers, S. R. (1993) · Brain Research · doi:10.1016/0006-8993(93)91304-b · Cited by 94
Stefano, G. B., Salzet, M., Magazine, H. I., & Bilfinger, T. V. (1998) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199806000-00003 · Cited by 93
Morphine- and anadamide-stimulated nitric oxide production inhibits presynaptic dopamine release
Stefano, G. B., Salzet, B., Rialas, C. M., et al. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00403-4 · Cited by 89
Prévot, V., Rialas, C. M., Croix, D., Salzet, M., Dupouy, J., Poulain, P., Beauvillain, J., & Stefano, G. B. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00066-3 · Cited by 89
Activation of the cannabinoid CB1 receptor may involve a W6.48/F3.36 rotamer toggle switch
Singh, R. K. B., Hurst, D. P., Barnett‐Norris, J., Lynch, D. L., Reggio, P. H., & Guarnieri, F. (2002) · Journal of Peptide Research · doi:10.1034/j.1399-3011.2002.21065.x · Cited by 87
Abood, M. E., Sauss, C., Fan, F., Tilton, C. L., & Martin, B. R. (1993) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(93)90546-6 · Cited by 85
Effects of cannabinoids on energy metabolism
Guzmán, M., & Sánchez, C. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00288-x · Cited by 84
Stefano, G. B., Salzet, B., & Salzet, M. (1997) · Brain Research · doi:10.1016/s0006-8993(96)01484-9 · Cited by 84
Hoffman, A. F., Riegel, A. C., & Lupica, C. R. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02773.x · Cited by 81
Howlett, A. C., Song, C., Berglund, B. A., Wilken, G. H., & Pigg, J. J. (1998) · Molecular Pharmacology · doi:10.1124/mol.53.3.504 · Cited by 79
Self-citationAnandamide‐induced mobilization of cytosolic Ca 2+ in endothelial cells
Mombouli, J., Schaeffer, G., Holzmann, S., et al. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702483 · Cited by 78
Harkany, T., Härtig, W., Berghuis, P., Dobszay, M. B., Zilberter, Y., Edwards, R. H., Mackie, K., & Ernfors, P. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02898.x · Cited by 77
The Development of Cannabinoid Antagonists
Barth, F., & Rinaldi, M. L. (1999) · Current Medicinal Chemistry · doi:10.2174/0929867306666220401143808 · Cited by 77
Chronic Morphine Treatment Inhibits Opioid Receptor Desensitization and Internalization
Eisinger, D. A., Ammer, H., & Schulz, R. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-23-10192.2002 · Cited by 76
Rubino, T., Forlani, G., Viganò, D., Zippel, R., & Parolaro, D. (2004) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2003.11.003 · Cited by 76
CB1 cannabinoid receptor-G protein association: a possible mechanism for differential signaling
Mukhopadhyay, S., Shim, J., Assi, A.-A. A., Norford, D. C., & Howlett, A. C. (2002) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(02)00153-6 · Cited by 75
Self-citationYamaji, K., Sarker, K. P., Kawahara, K., Iino, S., Yamakuchi, M., Abeyama, K., Hashiguchi, T., & Maruyama, I. (2003) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613475 · Cited by 74
Shivachar, A. C., Martin, B. R., & Ellis, E. F. (1996) · Biochemical Pharmacology · doi:10.1016/s0006-2952(95)02248-1 · Cited by 74
Shim, J., Welsh, W. J., & Howlett, A. C. (2003) · Biopolymers · doi:10.1002/bip.10424 · Cited by 74
Self-citationKobayashi, Y., Arai, S., Waku, K., & Sugiura, T. (2001) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a002904 · Cited by 74
Daniel, H., Rancillac, A., & Crépel, F. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2004.063263 · Cited by 72
Sugiura, T., Kodaka, T., Kondo, S., Tonegawa, T., Nakane, S., Kishimoto, S., Yamashita, A., & Waku, K. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6425 · Cited by 71
Regulation of adenylate cyclase by chronic exposure to cannabimimetic drugs.
Dill, J. A., & Howlett, A. C. (1988) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24581-5 · Cited by 71
Self-citationSelective and Potent Analgetics Derived from Cannabinoids
Johnson, M. R., Melvin, L. S., ALTHUIS, T. H., Bindra, J. S., Harbert, C. A., Milne, G. M., & Weissman, A. (1981) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1981.tb02605.x · Cited by 66
Cannabinoid Receptor‐Regulated Cyclic AMP Accumulation in the Rat Striatum
Bidaut‐Russell, M., & Hewlett, A. C. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb06379.x · Cited by 64
Priller, J., Briley, E. M., Mansouri, J., Devane, W. A., Mackie, K., & Felder, C. C. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10247-2 · Cited by 64
Reggio, P. H., & Traore, H. (2000) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(00)00185-7 · Cited by 62
Differential Receptor–G-Protein Coupling Evoked by Dissimilar Cannabinoid Receptor Agonists
Houston, D. B., & Howlett, A. C. (1998) · Cellular Signalling · doi:10.1016/s0898-6568(98)00013-8 · Cited by 62
Self-citationCabral, G. A., Harmon, K. W. N., & Carlisle, S. J. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-47611-8_24 · Cited by 61
The Endocannabinoid System Protects Rat Glioma Cells Against HIV-1 Tat Protein-induced Cytotoxicity
Esposito, G., Ligresti, A., Izzo, A. A., Bisogno, T., Ruvo, M., Rosa, M. D., Marzo, V. D., & Iuvone, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207170200 · Cited by 60
Phospholipase participation in cannabinoid-induced release of free arachidonic acid
BURSTEIN, S. H., Budrow, J., Debatis, M. E., Hunter, S. A., & Subramanian, A. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90163-5 · Cited by 59
Dual Role of Fyn in the Regulation of FAK+6,7 by Cannabinoids in Hippocampus
Derkinderen, P., Toutant, M., Kadaré, G., Girault, J., Ledent, C. A., & Parmentier, M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105630200 · Cited by 56
Hampson, R. E., Zhuang, S.-Y., Weiner, J. L., & Deadwyler, S. A. (2003) · Journal of Neurophysiology · doi:10.1152/jn.01161.2002 · Cited by 55
Azad, S. C., Marsicano, G., Eberlein, I., Putzke, J., Zieglgänsberger, W., Spanagel, R., & Lutz, B. (2001) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2001.01431.x · Cited by 53
Fimiani, C., Liberty, T., Aquirre, A. J., Amin, I., Ali, N., & Stefano, G. B. (1999) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(98)00068-9 · Cited by 52
Shapira, M., Gafni, M., & Sarne, Y. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00697-0 · Cited by 52
The Membrane Binding of Morphine, Diphenylhydantoin, and Tetrahydrocannabinol
Seeman, P. M., Chau-Wong, M., & Moyyen, S. (1972) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y72-173 · Cited by 51
Melvin, L. S., Milne, G. M., Johnson, M. R., Wilken, G. H., & Howlett, A. C. (1995) · PubMed · Cited by 51
Self-citationBreivogel, C. S., Walker, J. M., Huang, S. M., Roy, M. B., & Childers, S. R. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.02.017 · Cited by 49
Nie, J., & Lewis, D. L. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00335-9 · Cited by 48
Steffens, M., Szabó, B., Klar, M., Rominger, A., Zentner, J., & Feuerstein, T. J. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00318-x · Cited by 48
Electrophysiologic Properties of the Cannabinoids
Turkanis, S. A., & Karler, R. (1981) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1981.tb02625.x · Cited by 47
CB1 cannabinoid receptor‐mediated neurite remodeling in mouse neuroblastoma N1E‐115 cells
Zhou, D., & Song, Z. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.1160 · Cited by 46
Rubovitch, V., Gafni, M., & Sarne, Y. (2004) · Molecular Brain Research · doi:10.1016/j.molbrainres.2003.10.012 · Cited by 43
LeBeau, F. E. N., & Alger, B. E. (1998) · Journal of Neurophysiology · doi:10.1152/jn.1998.79.2.659 · Cited by 43
Roth, S. H., & Williams, P. J. (1979) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1979.tb13484.x · Cited by 41
Upham, B. L., Rummel, A. M., Carbone, J. M., Trosko, J. E., Ouyang, Y., Crawford, R. B., & Kaminski, N. E. (2003) · International Journal of Cancer · doi:10.1002/ijc.10899 · Cited by 38
Structure-Activity Relationships of Tricyclic and Nonclassical Bicyclic Cannabinoids
Melvin, L. S., & Johnson, M. R. (1987) · PsycEXTRA Dataset · doi:10.1037/e496672006-004 · Cited by 26
Zhou, D., & Song, Z. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03091-0 · Cited by 18
Cannabidiol-caused depression of spinal motoneuron responses in cats
Turkanis, S. A., & Karler, R. (1986) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(86)90235-2 · Cited by 17
Turkanis, S. A., Karler, R., & Partlow, L. M. (1991) · Brain Research · doi:10.1016/0006-8993(91)91239-w · Cited by 13
Steric Trigger as a Mechanism for CB1Cannabinoid Receptor Activation
Shim, J., & Howlett, A. C. (2004) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci040040c · Cited by 11
Self-citation
Cited by
Pertwee, R. G., Howlett, A. C., Abood, M. E., Alexander, S. P. H., Di Marzo, V., Elphick, M. R., Greasley, P. J., Hansen, H. S., Kunos, G., Mackie, K., et al. (2010) · Pharmacological Reviews · doi:10.1124/pr.110.003004 · Cited by 1,605
Self-citationEndocannabinoid Signaling and Synaptic Function
Castillo, P. E., Younts, T. J., Chávez, A. E., & Hashimotodani, Y. (2012) · Neuron · doi:10.1016/j.neuron.2012.09.020 · Cited by 1,120
Cannabinoid pharmacology: the first 66 years
Pertwee, R. G. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706406 · Cited by 782
Endocannabinoid Signaling and Long-Term Synaptic Plasticity
Heifets, B. D., & Castillo, P. E. (2009) · Annual Review of Physiology · doi:10.1146/annurev.physiol.010908.163149 · Cited by 482
New approaches and challenges to targeting the endocannabinoid system
Di Marzo, V. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.115 · Cited by 480
Metadata
- Authors
- Howlett, A. C.
- Venue
- Handbook of Experimental Pharmacology
- Publisher
- Springer-Verlag
- Published
- 2005-12-23
- Issue
- 168
- Pages
- 53-79
- OpenAlex
- W22941959
- Cited by
- 446
- References
- 180
- FWCI
- 19.90
- Type
- book chapter
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.